Latest Commercialization News

Altair Minerals is escalating its dispute with BHP over the undervaluation of its Olympic Domain Project by proceeding to South Australia’s Wardens Court. The junior explorer aims to defend the strategic and exploration value of its land amid ongoing negotiations with other majors.

BluGlass Limited reported a 16% rise in revenue to $11.7 million for FY25, driven by key US Department of Defense contracts and new partnerships. However, the company’s net loss increased 8% to nearly $11 million amid ongoing R&D investment and operational scaling.

Karoon Energy has significantly upgraded its Baúna Project 2P Reserves by 35%, extending the field’s economic life by seven years to 2039, driven by the recent FPSO acquisition and improved reservoir performance.

Kinetiko Energy has commenced drilling its second production test well at Brakfontein, applying optimized protocols following promising initial results. This marks a key step toward supplying gas to a pilot LNG plant planned for late 2026.

Pure Foods Tasmania has secured a $400,000 investment from entrepreneurs Jon Kontopos and Matthew Abrahams as part of a broader $750,000 capital raising effort, reinforcing confidence in the company’s turnaround plan ahead of its upcoming shareholder vote.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Metrics Real Estate Multi-Strategy Fund has released its inaugural annual report, revealing a strong start with $41.9 million profit before tax and distributions of 8.21 cents per unit following a $302.8 million IPO. The Fund’s diversified commercial real estate portfolio spans senior loans, mezzanine debt, and equity investments across Australia and New Zealand.

WiseTech Global posted robust FY25 results with 14% revenue growth and a 53% EBITDA margin excluding acquisition costs, while finalising the strategic e2open acquisition to broaden its global logistics software footprint.

Metrics Income Opportunities Trust reported a 6.6% increase in profit for FY25, achieving an 8.8% net return and maintaining strong portfolio diversification in private credit assets.

WiseTech Global reported robust FY25 results with a 14% revenue increase and a 53% EBITDA margin, boosted by strong CargoWise growth and the strategic acquisition of e2open. The company is poised to accelerate growth through AI innovations and a new commercial model.

BCAL Diagnostics has partnered with Sonic Healthcare Australia to broaden access to its innovative blood-based breast cancer test, BREASTEST plus™, across Sydney. This move formalizes a commercial rollout following successful trials and aims to improve early detection for women with dense breast tissue.

Proteomics International Laboratories reported a 26% increase in losses for FY2025, driven by higher operational costs as it advances its Promarker® diagnostic pipeline. Despite an 8% rise in revenue from ordinary activities, total income slipped 2%, underscoring ongoing commercialisation challenges.